Discontinued — last reported Q4 '25
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|
| Value | $2.63B | $2.63B | $2.63B | $0.00 | $80.00M |
| QoQ Change | — | +0.0% | +0.0% | -100.0% | — |